Overview

Nephrogenic Systemic Fibrosis With Gadollinum

Status:
Unknown status
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Recently there is increasing reports of NEPHROGENIIC SYSTEMIC FIBROSIS(NSF) in patients with severe renal failure mainly in patients under dialysis in whom gadollinum is being used. The investigators will evaluate the prevalence and severity of NSF in patients with different degree of renal failure whom underwent imaging with Gadolinum.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Imam Khomeini Hospital
Collaborator:
Tehran Heart Center